i2E Managementi2E Managementi2E Managementi2E Management
  • About
  • Portfolio
  • Team
  • Funds
  • Investor Login

Otologic Pharmaceutics

    Home library Otologic Pharmaceutics
    NextPrevious

    Otologic Pharmaceutics

    October 28, 2015
    0

    Otologic Pharmaceutics, Inc. (OP) is an Oklahoma headquartered organization formed specifically to commercialize promising technologies that address novel pharmacological solutions for hearing and balanced health.  The combined research and business experience of the Hough Ear Institute, (“HEI”), Oklahoma Medical Research Foundation, (“OMRF”) and American BioHealth Group, (“ABG”), have aligned under Otologic Pharmaceutics, Inc. to discover and commercialize therapeutic agents to combat the debilitating effects of sensorineural hearing loss (SNHL). Our Vision Is To Cure Hearing Loss.

    Avatar

    admin

    More posts by admin

    Related Projects:

    Alkami Technology

    View more

    Alkami Technology

    Alkami Technology

    Alkami Technology
    2015-12-29

    Benefit Informatics, Inc.

    View more

    Benefit Informatics, Inc.

    Benefit Informatics, Inc.

    Benefit Informatics, Inc.
    2015-12-25

    BioLytx

    View more

    BioLytx

    BioLytx

    BioLytx
    2015-12-24

    Crescendo Bioscience

    View more

    Crescendo Bioscience

    Crescendo Bioscience

    Crescendo Bioscience
    2015-12-17

    Docvia

    View more

    Docvia

    Docvia
    2015-12-12

    Exaptive

    View more

    Exaptive

    Exaptive

    Exaptive
    2015-12-04

    Expert TA

    View more

    Expert TA

    Expert TA

    Expert TA
    2015-12-02

    Hyalose LLC

    View more

    Hyalose LLC

    Hyalose LLC

    Hyalose LLC
    2015-11-21

    • Disclaimer & Disclosure

    Oklahoma City Location

    840 Research Parkway, Suite 250
    OKC, OK 73104
    PHONE 405/235-2305

    Click HERE for directions.

    Tulsa Location

    618 E. Third Street, Suite 1
    Tulsa, OK 74120
    PHONE 918/582-5592

    Click HERE for directions.

    • Disclaimer & Disclosure
    Copyright 2021 i2E, Inc. | All Rights Reserved
    • About
    • Portfolio
    • Team
    • Funds
    i2E Management